Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Food supplements should not be subject to nutrient profiling says EHPM
Food supplements should be exempted from nutrient profiling, trade organisation EHPM has said, as the European Food Safety Authority prepares its opinion on the system’s feasibility.
- Food supplements should not be subject to nutrient profiling says EHPM
Food supplements should be exempted from nutrient profiling, trade organisation EHPM has said, as the European Food Safety Authority prepares its opinion on the system’s feasibility.
- Food supplements should not be subject to nutrient profiling says EHPM
Food supplements should be exempted from nutrient profiling, trade organisation EHPM has said, as the European Food Safety Authority prepares its opinion on the system’s feasibility.
- Food supplements should not be subject to nutrient profiling says EHPM
Food supplements should be exempted from nutrient profiling, trade organisation EHPM has said, as the European Food Safety Authority prepares its opinion on the system’s feasibility.
- Food supplements should not be subject to nutrient profiling says EHPM
Food supplements should be exempted from nutrient profiling, trade organisation EHPM has said, as the European Food Safety Authority prepares its opinion on the system’s feasibility.
- Bioforce’s Prostasan is second product to be approved traditional medicine by UK’s MHRA
Bioforce USA announces that its A. Vogel Prostasan (saw palmetto capsules) is the second herbal supplement to be approved by the Medicines and Healthcare products Regulatory Agency in the U.K. under the European Directive on traditional herbal medicine products.
- Bioforce’s Prostasan is second product to be approved traditional medicine by UK’s MHRA
Bioforce USA announces that its A. Vogel Prostasan (saw palmetto capsules) is the second herbal supplement to be approved by the Medicines and Healthcare products Regulatory Agency in the U.K. under the European Directive on traditional herbal medicine products.
- Bioforce’s Prostasan is second product to be approved traditional medicine by UK’s MHRA
Bioforce USA announces that its A. Vogel Prostasan (saw palmetto capsules) is the second herbal supplement to be approved by the Medicines and Healthcare products Regulatory Agency in the U.K. under the European Directive on traditional herbal medicine products.
- Bioforce’s Prostasan is second product to be approved traditional medicine by UK’s MHRA
Bioforce USA announces that its A. Vogel Prostasan (saw palmetto capsules) is the second herbal supplement to be approved by the Medicines and Healthcare products Regulatory Agency in the U.K. under the European Directive on traditional herbal medicine products.
- Bioforce’s Prostasan is second product to be approved traditional medicine by UK’s MHRA
Bioforce USA announces that its A. Vogel Prostasan (saw palmetto capsules) is the second herbal supplement to be approved by the Medicines and Healthcare products Regulatory Agency in the U.K. under the European Directive on traditional herbal medicine products.
- Bioforce’s Prostasan is second product to be approved traditional medicine by UK’s MHRA
Bioforce USA announces that its A. Vogel Prostasan (saw palmetto capsules) is the second herbal supplement to be approved by the Medicines and Healthcare products Regulatory Agency in the U.K. under the European Directive on traditional herbal medicine products.
- IADSA keeps up the fight for reasonable food additive levels
The International Alliance for Dietary/Food Supplement Associations (IADSA) said that while it supports the adoption of some additives at the levels currently recommended for the Codex General Standard for Food Additives, a number of colours are still at recommended levels which are too low.
- IADSA keeps up the fight for reasonable food additive levels
The International Alliance for Dietary/Food Supplement Associations (IADSA) said that while it supports the adoption of some additives at the levels currently recommended for the Codex General Standard for Food Additives, a number of colours are still at recommended levels which are too low.
- IADSA keeps up the fight for reasonable food additive levels
The International Alliance for Dietary/Food Supplement Associations (IADSA) said that while it supports the adoption of some additives at the levels currently recommended for the Codex General Standard for Food Additives, a number of colours are still at recommended levels which are too low.
- IADSA keeps up the fight for reasonable food additive levels
The International Alliance for Dietary/Food Supplement Associations (IADSA) said that while it supports the adoption of some additives at the levels currently recommended for the Codex General Standard for Food Additives, a number of colours are still at recommended levels which are too low.
- IADSA keeps up the fight for reasonable food additive levels
The International Alliance for Dietary/Food Supplement Associations (IADSA) said that while it supports the adoption of some additives at the levels currently recommended for the Codex General Standard for Food Additives, a number of colours are still at recommended levels which are too low.
- ECJ: Garlic Extract Powder Capsules Are Not Medicinal Products
The European Court of Justice has held that garlic extract powder capsules do not correspond to the definition either of a medicinal product by presentation or of a medicinal product by function. Therefore, they cannot be classified as a medicinal product. The Court also holds that the Federal Republic of Germany has failed to fulfil its Treaty obligations concerning the free movement of goods.
- ECJ: Garlic Extract Powder Capsules Are Not Medicinal Products
The European Court of Justice has held that garlic extract powder capsules do not correspond to the definition either of a medicinal product by presentation or of a medicinal product by function. Therefore, they cannot be classified as a medicinal product. The Court also holds that the Federal Republic of Germany has failed to fulfil its Treaty obligations concerning the free movement of goods.
- ECJ: Garlic Extract Powder Capsules Are Not Medicinal Products
The European Court of Justice has held that garlic extract powder capsules do not correspond to the definition either of a medicinal product by presentation or of a medicinal product by function. Therefore, they cannot be classified as a medicinal product. The Court also holds that the Federal Republic of Germany has failed to fulfil its Treaty obligations concerning the free movement of goods.
- ECJ: Garlic Extract Powder Capsules Are Not Medicinal Products
The European Court of Justice has held that garlic extract powder capsules do not correspond to the definition either of a medicinal product by presentation or of a medicinal product by function. Therefore, they cannot be classified as a medicinal product. The Court also holds that the Federal Republic of Germany has failed to fulfil its Treaty obligations concerning the free movement of goods.
- ECJ: Garlic Extract Powder Capsules Are Not Medicinal Products
The European Court of Justice has held that garlic extract powder capsules do not correspond to the definition either of a medicinal product by presentation or of a medicinal product by function. Therefore, they cannot be classified as a medicinal product. The Court also holds that the Federal Republic of Germany has failed to fulfil its Treaty obligations concerning the free movement of goods.
- ECJ: Garlic Extract Powder Capsules Are Not Medicinal Products
The European Court of Justice has held that garlic extract powder capsules do not correspond to the definition either of a medicinal product by presentation or of a medicinal product by function. Therefore, they cannot be classified as a medicinal product. The Court also holds that the Federal Republic of Germany has failed to fulfil its Treaty obligations concerning the free movement of goods.
- ECJ: Garlic Extract Powder Capsules Are Not Medicinal Products
The European Court of Justice has held that garlic extract powder capsules do not correspond to the definition either of a medicinal product by presentation or of a medicinal product by function. Therefore, they cannot be classified as a medicinal product. The Court also holds that the Federal Republic of Germany has failed to fulfil its Treaty obligations concerning the free movement of goods.
- ECJ: Garlic Extract Powder Capsules Are Not Medicinal Products
The European Court of Justice has held that garlic extract powder capsules do not correspond to the definition either of a medicinal product by presentation or of a medicinal product by function. Therefore, they cannot be classified as a medicinal product. The Court also holds that the Federal Republic of Germany has failed to fulfil its Treaty obligations concerning the free movement of goods.
- EBF hails European Court of Justice garlic verdict
The European Court of Justice’s decision that garlic extract powder capsules cannot be classified as a medicinal product has been welcomed by the European Botanical Forum (EBF).
- EBF hails European Court of Justice garlic verdict
The European Court of Justice’s decision that garlic extract powder capsules cannot be classified as a medicinal product has been welcomed by the European Botanical Forum (EBF).
- EBF hails European Court of Justice garlic verdict
The European Court of Justice’s decision that garlic extract powder capsules cannot be classified as a medicinal product has been welcomed by the European Botanical Forum (EBF).
- EBF hails European Court of Justice garlic verdict
The European Court of Justice’s decision that garlic extract powder capsules cannot be classified as a medicinal product has been welcomed by the European Botanical Forum (EBF).
- EBF hails European Court of Justice garlic verdict
The European Court of Justice’s decision that garlic extract powder capsules cannot be classified as a medicinal product has been welcomed by the European Botanical Forum (EBF).
- Updated risk management model for setting maximum levels published
An updated version of the risk management model reviewed in the European Commission’s Orientation Paper on maximum and minimum levels for vitamins and minerals has been published this month. Available in the November 2 edition of peer review journal ‘Food Science and Technology Bulletin: Functional Foods’, the model has been updated using the latest data from the UK and Ireland.
- Updated risk management model for setting maximum levels published
An updated version of the risk management model reviewed in the European Commission’s Orientation Paper on maximum and minimum levels for vitamins and minerals has been published this month. Available in the November 2 edition of peer review journal ‘Food Science and Technology Bulletin: Functional Foods’, the model has been updated using the latest data from the UK and Ireland.
- Updated risk management model for setting maximum levels published
An updated version of the risk management model reviewed in the European Commission’s Orientation Paper on maximum and minimum levels for vitamins and minerals has been published this month. Available in the November 2 edition of peer review journal ‘Food Science and Technology Bulletin: Functional Foods’, the model has been updated using the latest data from the UK and Ireland.
- Updated risk management model for setting maximum levels published
An updated version of the risk management model reviewed in the European Commission’s Orientation Paper on maximum and minimum levels for vitamins and minerals has been published this month. Available in the November 2 edition of peer review journal ‘Food Science and Technology Bulletin: Functional Foods’, the model has been updated using the latest data from the UK and Ireland.
- Updated risk management model for setting maximum levels published
An updated version of the risk management model reviewed in the European Commission’s Orientation Paper on maximum and minimum levels for vitamins and minerals has been published this month. Available in the November 2 edition of peer review journal ‘Food Science and Technology Bulletin: Functional Foods’, the model has been updated using the latest data from the UK and Ireland.
- Updated risk management model for setting maximum levels published
An updated version of the risk management model reviewed in the European Commission’s Orientation Paper on maximum and minimum levels for vitamins and minerals has been published this month. Available in the November 2 edition of peer review journal ‘Food Science and Technology Bulletin: Functional Foods’, the model has been updated using the latest data from the UK and Ireland.
- EAS clarifies EU and national boundaries for companies launching food supplements
An upcoming workshop taking place on 20 Febuary 2008 in Brussels will take participants through the process from notification strategies to distribution and market practice, with EAS experts giving tips on future regulatory developments for mid- and long-term product strategies.
- EAS clarifies EU and national boundaries for companies launching food supplements
An upcoming workshop taking place on 20 Febuary 2008 in Brussels will take participants through the process from notification strategies to distribution and market practice, with EAS experts giving tips on future regulatory developments for mid- and long-term product strategies.
- EAS clarifies EU and national boundaries for companies launching food supplements
An upcoming workshop taking place on 20 Febuary 2008 in Brussels will take participants through the process from notification strategies to distribution and market practice, with EAS experts giving tips on future regulatory developments for mid- and long-term product strategies.
- EAS clarifies EU and national boundaries for companies launching food supplements
An upcoming workshop taking place on 20 Febuary 2008 in Brussels will take participants through the process from notification strategies to distribution and market practice, with EAS experts giving tips on future regulatory developments for mid- and long-term product strategies.
- EAS clarifies EU and national boundaries for companies launching food supplements
An upcoming workshop taking place on 20 Febuary 2008 in Brussels will take participants through the process from notification strategies to distribution and market practice, with EAS experts giving tips on future regulatory developments for mid- and long-term product strategies.
- Codex to redraft health claims recommendations
Codex has sent its draft health claims recommendations back to the drawing board following concerns over the weight given to the different types of evidence required for scientific substantiation, IADSA has revealed. The text, which will go through an eight-step process to completion, contained many references to the significance of clinical trials and their desirability as a pre-requisite for a claim. But opposition from the International Alliance of Dietary/Food Supplement Associations (IADSA), a number of countries and other non-governmental organisations has resulted in the topic being referred back to step 2 in the process for redrafting.
- Codex to redraft health claims recommendations
Codex has sent its draft health claims recommendations back to the drawing board following concerns over the weight given to the different types of evidence required for scientific substantiation, IADSA has revealed. The text, which will go through an eight-step process to completion, contained many references to the significance of clinical trials and their desirability as a pre-requisite for a claim. But opposition from the International Alliance of Dietary/Food Supplement Associations (IADSA), a number of countries and other non-governmental organisations has resulted in the topic being referred back to step 2 in the process for redrafting.
- Codex to redraft health claims recommendations
Codex has sent its draft health claims recommendations back to the drawing board following concerns over the weight given to the different types of evidence required for scientific substantiation, IADSA has revealed. The text, which will go through an eight-step process to completion, contained many references to the significance of clinical trials and their desirability as a pre-requisite for a claim. But opposition from the International Alliance of Dietary/Food Supplement Associations (IADSA), a number of countries and other non-governmental organisations has resulted in the topic being referred back to step 2 in the process for redrafting.
- Codex to redraft health claims recommendations
Codex has sent its draft health claims recommendations back to the drawing board following concerns over the weight given to the different types of evidence required for scientific substantiation, IADSA has revealed. The text, which will go through an eight-step process to completion, contained many references to the significance of clinical trials and their desirability as a pre-requisite for a claim. But opposition from the International Alliance of Dietary/Food Supplement Associations (IADSA), a number of countries and other non-governmental organisations has resulted in the topic being referred back to step 2 in the process for redrafting.
- Codex to redraft health claims recommendations
Codex has sent its draft health claims recommendations back to the drawing board following concerns over the weight given to the different types of evidence required for scientific substantiation, IADSA has revealed. The text, which will go through an eight-step process to completion, contained many references to the significance of clinical trials and their desirability as a pre-requisite for a claim. But opposition from the International Alliance of Dietary/Food Supplement Associations (IADSA), a number of countries and other non-governmental organisations has resulted in the topic being referred back to step 2 in the process for redrafting.
- Codex to redraft health claims recommendations
Codex has sent its draft health claims recommendations back to the drawing board following concerns over the weight given to the different types of evidence required for scientific substantiation, IADSA has revealed. The text, which will go through an eight-step process to completion, contained many references to the significance of clinical trials and their desirability as a pre-requisite for a claim. But opposition from the International Alliance of Dietary/Food Supplement Associations (IADSA), a number of countries and other non-governmental organisations has resulted in the topic being referred back to step 2 in the process for redrafting.
- Regulatory change a boost for emerging supplement markets says IADSA
Changing regulations for dietary supplements across the globe has led to increased consumer demand in emerging markets, the International Alliance of Dietary/Food Supplements (IADSA) has said. Speaking at a recent international conference on food supplements in Ankara, Mr Zambetti showed that while developed markets such as the European Union, the UK and the US are growing at an average of four to six percent per year, emerging markets see an average annual growth of 17 percent.
- Regulatory change a boost for emerging supplement markets says IADSA
Changing regulations for dietary supplements across the globe has led to increased consumer demand in emerging markets, the International Alliance of Dietary/Food Supplements (IADSA) has said. Speaking at a recent international conference on food supplements in Ankara, Mr Zambetti showed that while developed markets such as the European Union, the UK and the US are growing at an average of four to six percent per year, emerging markets see an average annual growth of 17 percent.
- Regulatory change a boost for emerging supplement markets says IADSA
Changing regulations for dietary supplements across the globe has led to increased consumer demand in emerging markets, the International Alliance of Dietary/Food Supplements (IADSA) has said. Speaking at a recent international conference on food supplements in Ankara, Mr Zambetti showed that while developed markets such as the European Union, the UK and the US are growing at an average of four to six percent per year, emerging markets see an average annual growth of 17 percent.
- Regulatory change a boost for emerging supplement markets says IADSA
Changing regulations for dietary supplements across the globe has led to increased consumer demand in emerging markets, the International Alliance of Dietary/Food Supplements (IADSA) has said. Speaking at a recent international conference on food supplements in Ankara, Mr Zambetti showed that while developed markets such as the European Union, the UK and the US are growing at an average of four to six percent per year, emerging markets see an average annual growth of 17 percent.
- Regulatory change a boost for emerging supplement markets says IADSA
Changing regulations for dietary supplements across the globe has led to increased consumer demand in emerging markets, the International Alliance of Dietary/Food Supplements (IADSA) has said. Speaking at a recent international conference on food supplements in Ankara, Mr Zambetti showed that while developed markets such as the European Union, the UK and the US are growing at an average of four to six percent per year, emerging markets see an average annual growth of 17 percent.
- Novel Foods revision should simplify procedure says EAS
The European Commission’s proposal to revise the Novel Foods Regulation should simplify the process, Brussels food and nutrition policy consultancy EAS has said. EAS Regulatory Adviser Pieter Lagae highlighted in a podcast interview that with the proposed revision based largely on discussions with industry and stakeholders, it should result in a shorter, less complex procedure for both countries within the European Union (EU) and outside of it (third countries).
- Novel Foods revision should simplify procedure says EAS
The European Commission’s proposal to revise the Novel Foods Regulation should simplify the process, Brussels food and nutrition policy consultancy EAS has said. EAS Regulatory Adviser Pieter Lagae highlighted in a podcast interview that with the proposed revision based largely on discussions with industry and stakeholders, it should result in a shorter, less complex procedure for both countries within the European Union (EU) and outside of it (third countries).
- Novel Foods revision should simplify procedure says EAS
The European Commission’s proposal to revise the Novel Foods Regulation should simplify the process, Brussels food and nutrition policy consultancy EAS has said. EAS Regulatory Adviser Pieter Lagae highlighted in a podcast interview that with the proposed revision based largely on discussions with industry and stakeholders, it should result in a shorter, less complex procedure for both countries within the European Union (EU) and outside of it (third countries).
- Novel Foods revision should simplify procedure says EAS
The European Commission’s proposal to revise the Novel Foods Regulation should simplify the process, Brussels food and nutrition policy consultancy EAS has said. EAS Regulatory Adviser Pieter Lagae highlighted in a podcast interview that with the proposed revision based largely on discussions with industry and stakeholders, it should result in a shorter, less complex procedure for both countries within the European Union (EU) and outside of it (third countries).
- Novel Foods revision should simplify procedure says EAS
The European Commission’s proposal to revise the Novel Foods Regulation should simplify the process, Brussels food and nutrition policy consultancy EAS has said. EAS Regulatory Adviser Pieter Lagae highlighted in a podcast interview that with the proposed revision based largely on discussions with industry and stakeholders, it should result in a shorter, less complex procedure for both countries within the European Union (EU) and outside of it (third countries).
- Novel Foods proposal abolishes majority exclusivity rights
Pieter Lagae, Regulatory Adviser at Brussels food and nutrition policy consultancy EAS, said that while the current procedure links authorised use of a novel food to the specific applicant, the revision will allow for more general use of approved novel foods.
- Novel Foods proposal abolishes majority exclusivity rights
Pieter Lagae, Regulatory Adviser at Brussels food and nutrition policy consultancy EAS, said that while the current procedure links authorised use of a novel food to the specific applicant, the revision will allow for more general use of approved novel foods.
- Novel Foods proposal abolishes majority exclusivity rights
Pieter Lagae, Regulatory Adviser at Brussels food and nutrition policy consultancy EAS, said that while the current procedure links authorised use of a novel food to the specific applicant, the revision will allow for more general use of approved novel foods.
- Novel Foods proposal abolishes majority exclusivity rights
Pieter Lagae, Regulatory Adviser at Brussels food and nutrition policy consultancy EAS, said that while the current procedure links authorised use of a novel food to the specific applicant, the revision will allow for more general use of approved novel foods.
- Novel Foods proposal abolishes majority exclusivity rights
Pieter Lagae, Regulatory Adviser at Brussels food and nutrition policy consultancy EAS, said that while the current procedure links authorised use of a novel food to the specific applicant, the revision will allow for more general use of approved novel foods.
- EAS releases essential guide to marketing nutritional products in Europe
Food and nutrition policy consultancy EAS has released its 2008 easy-to-follow guide to help companies successfully enter the European Union’s (EU) nutritional products market.
- EAS releases essential guide to marketing nutritional products in Europe
Food and nutrition policy consultancy EAS has released its 2008 easy-to-follow guide to help companies successfully enter the European Union’s (EU) nutritional products market.
- EAS releases essential guide to marketing nutritional products in Europe
Food and nutrition policy consultancy EAS has released its 2008 easy-to-follow guide to help companies successfully enter the European Union’s (EU) nutritional products market.
- EAS releases essential guide to marketing nutritional products in Europe
Food and nutrition policy consultancy EAS has released its 2008 easy-to-follow guide to help companies successfully enter the European Union’s (EU) nutritional products market.
- Keep supplements exempt from nutrient profiling says ERNA
Food supplements should be exempt from the provisions of nutrient profiles because of their small size and dose form, the European Responsible Nutrition Alliance (ERNA) said.
- Keep supplements exempt from nutrient profiling says ERNA
Food supplements should be exempt from the provisions of nutrient profiles because of their small size and dose form, the European Responsible Nutrition Alliance (ERNA) said.
- Keep supplements exempt from nutrient profiling says ERNA
Food supplements should be exempt from the provisions of nutrient profiles because of their small size and dose form, the European Responsible Nutrition Alliance (ERNA) said.
- Keep supplements exempt from nutrient profiling says ERNA
Food supplements should be exempt from the provisions of nutrient profiles because of their small size and dose form, the European Responsible Nutrition Alliance (ERNA) said.
- Keep supplements exempt from nutrient profiling says ERNA
Food supplements should be exempt from the provisions of nutrient profiles because of their small size and dose form, the European Responsible Nutrition Alliance (ERNA) said.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
|
 EAS Expertise
Since its creation in 1992, EAS has operated and specialised in the area of food, nutrition and health. As a team of skilled, experienced food law and policy advisors, EAS experts work with companies and government bodies to find practical solutions to often complicated problems. We excel in finding practical solutions to often complex problems. EAS consultants speak at national, European and international conferences and workshops, working with bodies across the world to deliver up-to-date information, expert advice and solutions in the changing marketplace.
This one day workshop will guide companies through the practicalities of launching food supplement products in Europe. Companies will get a clear picture of the different legislations and practices in Europe’s markets, from notification requirements to product distribution, and find out how to avoid common pitfalls to a successful product launch.
| THE PROGRAMME |
|
| |
|
| 09.00-09.30 |
Registration |
| 09.30-09.45 |
Welcome address and introduction |
| 09.45-10.10 |
Notification strategies: an entrance ticket into Europe?
EAS Regulatory Adviser Pieter Lagae will explain the first step in the process – notification procedures across
different Member States. He will show the benefits of a solid notification strategy towards launching a product
in and across the EU, highlighting:
• Basic requirements for notifying your food supplement product in the EU
• Most demanding versus least demanding Member States
• Advantages and disadvantages of notifying your product in specific countries |
| 10.10-10.30 |
Mutual recognition in practice: reality or fiction
Does the principle of mutual recognition exist in practice across Member States when marketing food supplements?
EAS Regulatory Affairs Manager - Nutritional Products, Katarina Wagner, will explain how mutual recognition works
in the European Union and where it may offer a practical solution to marketing your supplements across national
borders, clarifying:
• How Member States apply the mutual recognition principle
• Where the main opportunities and pitfalls lie
• Current and future trends to be aware of when planning a business strategy |
| 10.30-11.00 |
Question and Answer Session |
| 11.00-11.15 |
COFFEE BREAK |
| 11.15-11.40 |
Vitamins and minerals: towards one product formula across Europe
An outline of the permitted vitamin and mineral substances and their levels across Europe, with Pieter Lagae
explaining how national derogations work and the future impact of steps towards EU harmonisation on businesses. |
| 11.40-12.00 |
Herbs and other bioactive substances: diversity in national approaches
Which herbs and bioactive substances can be used in food supplements in Europe? Katarina Wagner will give an
explanation of the national rules surrounding these ingredients, outlining key areas of opportunity and concern. |
| 12.00-12.30 |
Distribution and market practice: adapting to the climate
Successfully launching a food supplement in Europe involves knowing where the widest distribution possibilities lie.
Katarina Wagner and EAS Nutritional Product Regulatory Affairs Manager Stefanie Geiser, will give an overview of
which countries have the best market practice for specific product profiles, and detail where organised controls exist. |
| 12.30-13.00 |
Question and Answer Session |
| 13.00-13.45 |
LUNCH |
| 13.45-14.15 |
Labelling compliance: do’s and don’ts
A common stumbling point for companies is product labelling. Pieter Lagae will explain the EU requirements for a
food supplement label, and give practical examples of the do’s and don’ts in food supplement labelling. |
| 14.15-15.00 |
EU Claims Regulation: the practical impact for product marketing
Stefanie Geiser will clarify what the recently introduced EU Claims Regulation means in practical terms for companies
looking to launch products in the EU. She will cover:
• Status of work towards the draft ‘Community list’ on Article 13 health claims, including latest Commission/
Member States’ discussions and timings for EFSA evaluation
• Member States’ policies on ‘national Article 13 lists’
• Impact of transition periods and timing for required product compliance |
| 15.00-15.30 |
Question and Answer Session |
| 15.30 |
End of Workshop |
The Biographies
Katarina Wagner is Regulatory Affairs Manager - Nutritional Products at EAS’ Brussels office. As a specialist in providing regulatory and strategic advice for the marketing of nutritional products in Central and Eastern Europe, she is a biologist (University of Bratislava - Slovakia, and University of Bayreuth - Germany) and has gained an MBA in International Marketing at University of Reutlingen - Germany. Katarina manages the EAS international network of independent regulatory and technical experts.
Pieter Lagae is a Regulatory Adviser at EAS, also based at the Brussels office. He advises clients on how to launch their nutritional products into different markets, specialising in product formula and label  compliance, as well as notification dossiers. Pieter has a masters in Biomedical Sciences (KU Leuven - Belgium) and Intellectual Rights (KU Brussels - Belgium). Before joining EAS he has worked in the field of Regulatory Affairs for pharmaceuticals.
Stefanie Geiser is Regulatory Affairs Manager at the EAS branch based in Italy. While following the European Food Safety Authority (EFSA) developments in Parma closely, at EAS-Italy she assists companies in overcoming regulatory barriers for the EU approval of their health claims and innovative food ingredients. Stefanie has specialised in biochemistry and plant physiology (University of Aachen - Germany, and University of Bologna - Italy). Following her studies she worked in the field of organic food products at the European Commission, DG VI, Agriculture. Since joining EAS in 1995 she has been an adviser on regulatory issues to European and international industry associations.
Click here for the Regisration Form |